![]() |
市场调查报告书
商品编码
1930118
全球机器人手术市场:市场规模、占有率、成长率、行业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034 年)Robotic Surgical Procedures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受微创手术日益普及和手术机器人技术持续创新的推动,全球机器人手术市场正成为先进医疗技术领域成长最快的细分市场之一。根据 Fortune Business Insights 预测,该市场规模预计将在 2025 年达到 133.2 亿美元,并在 2026 年显着增长至 159 亿美元,到 2034 年将达到 546.1 亿美元。预计 2026 年至 2034 年的复合年增长率将达到 16.68%。
市场概览
机器人手术(也称为机器人辅助手术)使外科医生能够以更高的精确度、灵活性和控制力完成复杂的手术。这些手术广泛应用于一般外科、妇科、泌尿外科和骨科等专科。微创技术、更短的住院时间、更快的復健速度和更佳的临床疗效日益受到青睐,这些都是推动机器人手术在全球普及的关键因素。
儘管新冠疫情在2020年导致市场急剧下滑14.3%,但此后市场呈现强劲復苏态势。疫情期间,由于择期手术的取消和延期,需求一度下降,但手术量的恢復已使市场成长恢復到疫情前的水准。
新冠疫情的影响
由于择期手术的大规模取消,新冠疫情对机器人手术市场造成了负面影响。根据CovidSurg Collaborative统计,在疫情高峰期,全球约有2800万例择期手术被取消或延期。此外,包括直觉外科(Intuitive Surgical)在内的多家大型公司报告称,2020年上半年收入下降约6.0%,主要原因是手术量下降和供应链中断。然而,疫情后的復苏已显着增强了市场需求。
市场规模及主要亮点
依地区划分,北美在2025年占全球市场的73.89%。这得益于该地区较高的手术量、先进的医疗基础设施、有利的报销政策以及机器人系统的快速普及。
成长因素
癌症、心血管疾病和骨科疾病等慢性病的增加是市场成长的主要驱动力。例如,前列腺癌病例预计将持续增长,从而促使机器人辅助根治性前列腺切除术数量的增加。此外,人口老化和久坐的生活方式也推动了对外科手术介入需求的成长。
技术进步也发挥关键作用。领先企业不断推出新一代机器人系统。例如,Intuitive Surgical公司获得FDA批准的达文西SP系统可实现复杂泌尿外科手术的单孔入路,显着提高手术效率。
市场限制因子
儘管市场具有巨大的成长潜力,但机器人手术系统的高昂实施和维护成本也为市场带来了挑战。像达文西机器人这样的系统每年的维护成本可能高达 10 万至 15 万美元,这意味着机器人手术比传统腹腔镜手术贵 3000 至 6000 美元。这些成本壁垒限制了机器人手术的普及,尤其是在新兴经济体。
依应用领域划分,预计到 2026 年,普通外科手术将占市场主导地位,市场占有率达到 32.02%。这主要得益于子宫切除术、肾臟切除术和心臟瓣膜修復术等手术量的激增。由于骨科疾病的增加以及专业机器人平台的普及,预计骨科领域的复合年增长率将更高。泌尿外科和妇科预计在预测期内也将强劲成长。
The global robotic surgical procedures market has emerged as one of the fastest-growing segments within advanced medical technologies, driven by the increasing adoption of minimally invasive surgeries and continuous innovation in surgical robotics. According to Fortune Business Insights, the market was valued at USD 13.32 billion in 2025 and is projected to expand significantly to USD 15.9 billion in 2026, reaching USD 54.61 billion by 2034, registering a robust CAGR of 16.68% during 2026-2034.
Market Overview
Robotic surgery, also referred to as robot-assisted surgery, enables surgeons to perform complex procedures with enhanced precision, flexibility, and control. These procedures are widely used in general surgery, gynecology, urology, orthopedics, and other specialties. The growing preference for minimally invasive techniques, reduced hospital stays, faster recovery times, and improved clinical outcomes are major factors accelerating the adoption of robotic surgical procedures globally.
Despite a sharp decline of -14.3% in 2020 due to the COVID-19 pandemic, the market has shown a strong recovery trajectory. The cancellation and postponement of elective surgeries during the pandemic temporarily reduced demand; however, the resumption of surgical volumes has restored growth to pre-pandemic levels.
Impact of COVID-19
The COVID-19 pandemic negatively impacted the robotic surgical procedures market due to widespread cancellation of elective surgeries. According to the CovidSurg Collaborative, approximately 28 million elective surgeries were cancelled or postponed globally during peak disruption. Additionally, leading players such as Intuitive Surgical reported a revenue decline of around -6.0% in the first half of 2020, mainly due to reduced procedure volumes and supply chain disruptions. Nevertheless, post-pandemic recovery has significantly strengthened market demand.
Market Size and Key Highlights
In terms of regional dominance, North America accounted for 73.89% of the global market share in 2025, driven by high procedure volumes, advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of robotic systems.
Driving Factors
The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and orthopedic conditions is a key driver of market growth. For instance, prostate cancer cases are expected to increase steadily, leading to higher volumes of robot-assisted prostatectomy procedures. Additionally, the growing geriatric population and sedentary lifestyles are further contributing to the increased demand for surgical interventions.
Technological advancements also play a critical role. Leading companies are continuously introducing next-generation robotic systems. For example, Intuitive Surgical's FDA-approved da Vinci SP system has enabled single-port access for complex urological procedures, significantly enhancing surgical efficiency.
Market Restraints
Despite strong growth potential, the market faces challenges related to high acquisition and maintenance costs of robotic surgical systems. Annual maintenance costs for systems such as the da Vinci robot range between USD 100,000 and USD 150,000, while robotic procedures can cost USD 3,000-6,000 more than conventional laparoscopic surgeries. These cost barriers limit adoption, particularly in emerging economies.
By application, general surgery dominated the market, holding a 32.02% share in 2026, supported by the high volume of procedures such as hysterectomy, nephrectomy, and cardiac valve repair. Orthopedics is expected to grow at a higher CAGR due to increasing orthopedic disorders and the introduction of specialized robotic platforms. Urology and gynecology are also projected to witness strong growth during the forecast period.
Competitive Landscape
The market is largely dominated by Intuitive Surgical, owing to its strong product portfolio and global presence. Other key players include Stryker, Medtronic, Johnson & Johnson Services, Smith & Nephew, Zimmer Biomet, and CMR Surgical. Strategic acquisitions and partnerships remain a key trend, such as Medtronic's acquisition of Digital Surgery in 2020 to strengthen AI-driven robotic platforms.
Conclusion
In conclusion, the global robotic surgical procedures market is set for exceptional growth from USD 13.32 billion in 2025 to USD 54.61 billion by 2034, fueled by rising chronic disease prevalence, technological innovation, and increasing adoption of minimally invasive surgeries. Although high system costs remain a challenge, expanding reimbursement policies and continuous product advancements are expected to sustain strong market momentum throughout the forecast period.
Segmentation
By Application
By Geography